Cargando…

Fusobacterium nucleatum induces MDSCs enrichment via activation the NLRP3 inflammosome in ESCC cells, leading to cisplatin resistance

BACKGROUND: To analyse the regulatory effect of Fusobacterium nucleatum (Fn) on NOD-like receptor protein 3 (NLRP3) and myeloid-derived suppressor cells (MDSCs) in oesophageal squamous cell carcinoma (ESCC) as well as its effect on cisplatin (CDDP) therapy and to explore its clinical significance. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Mengxia, Liu, Yiwen, Zhang, Zheyuan, Yang, Haijun, Dai, Ningtao, Zhang, Ning, Sun, Wei, Guo, Yibo, Kong, Jinyu, Wang, Xiaopeng, Wang, Min, Zhou, Fuyou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891225/
https://www.ncbi.nlm.nih.gov/pubmed/35435776
http://dx.doi.org/10.1080/07853890.2022.2061045
_version_ 1784881098057056256
author Liang, Mengxia
Liu, Yiwen
Zhang, Zheyuan
Yang, Haijun
Dai, Ningtao
Zhang, Ning
Sun, Wei
Guo, Yibo
Kong, Jinyu
Wang, Xiaopeng
Wang, Min
Zhou, Fuyou
author_facet Liang, Mengxia
Liu, Yiwen
Zhang, Zheyuan
Yang, Haijun
Dai, Ningtao
Zhang, Ning
Sun, Wei
Guo, Yibo
Kong, Jinyu
Wang, Xiaopeng
Wang, Min
Zhou, Fuyou
author_sort Liang, Mengxia
collection PubMed
description BACKGROUND: To analyse the regulatory effect of Fusobacterium nucleatum (Fn) on NOD-like receptor protein 3 (NLRP3) and myeloid-derived suppressor cells (MDSCs) in oesophageal squamous cell carcinoma (ESCC) as well as its effect on cisplatin (CDDP) therapy and to explore its clinical significance. METHODS: Fn infection, NLRP3 expression and MDSCs infiltration in ESCC tissues were detected by RNAscope and immunohistochemistry (IHC). The correlation between these three factors and the clinicopathological features and survival of ESCC patients was analysed. A coculture system of human peripheral blood monocytes (PBMCs) and ESCC cells was established to simulate the tumour microenvironment. In vitro and in vivo models were used to analyse the effects of Fn on the percentage of MDSCs in the coculture system and the NLRP3 expression level and CDDP sensitivity of ESCC cells. RESULTS: Fn infection was consistent with high NLRP3 expression and MDSCs enrichment in ESCC tissues. Moreover, the survival time of ESCC patients was significantly shortened under Fn infection, high NLRP3 expression and MDSCs enrichment. In the in vitro and in vivo models, Fn induced abundant enrichment of MDSCs by inducing high expression of NLRP3 in ESCC cells and reducing the sensitivity of ESCC cells to CDDP. CONCLUSIONS: Fn infection can induce high expression of NLRP3 in ESCC, lead to MDSCs enrichment, weaken the body's antitumour immunity, and lead to CDDP treatment resistance. The effective elimination of Fn and the inhibition of MDSCs enrichment may provide new strategies and treatments for ESCC. HIGHLIGHTS: The survival of ESCC patients with Fn infection, high NLRP3 expression and MDSCs enrichment was significantly shortened. Fn infection could cause CDDP resistance in ESCC. Fn could induce the enrichment of MDSCs in the tumour microenvironment by activating NLRP3 in ESCC cells.
format Online
Article
Text
id pubmed-9891225
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-98912252023-02-02 Fusobacterium nucleatum induces MDSCs enrichment via activation the NLRP3 inflammosome in ESCC cells, leading to cisplatin resistance Liang, Mengxia Liu, Yiwen Zhang, Zheyuan Yang, Haijun Dai, Ningtao Zhang, Ning Sun, Wei Guo, Yibo Kong, Jinyu Wang, Xiaopeng Wang, Min Zhou, Fuyou Ann Med Oncology BACKGROUND: To analyse the regulatory effect of Fusobacterium nucleatum (Fn) on NOD-like receptor protein 3 (NLRP3) and myeloid-derived suppressor cells (MDSCs) in oesophageal squamous cell carcinoma (ESCC) as well as its effect on cisplatin (CDDP) therapy and to explore its clinical significance. METHODS: Fn infection, NLRP3 expression and MDSCs infiltration in ESCC tissues were detected by RNAscope and immunohistochemistry (IHC). The correlation between these three factors and the clinicopathological features and survival of ESCC patients was analysed. A coculture system of human peripheral blood monocytes (PBMCs) and ESCC cells was established to simulate the tumour microenvironment. In vitro and in vivo models were used to analyse the effects of Fn on the percentage of MDSCs in the coculture system and the NLRP3 expression level and CDDP sensitivity of ESCC cells. RESULTS: Fn infection was consistent with high NLRP3 expression and MDSCs enrichment in ESCC tissues. Moreover, the survival time of ESCC patients was significantly shortened under Fn infection, high NLRP3 expression and MDSCs enrichment. In the in vitro and in vivo models, Fn induced abundant enrichment of MDSCs by inducing high expression of NLRP3 in ESCC cells and reducing the sensitivity of ESCC cells to CDDP. CONCLUSIONS: Fn infection can induce high expression of NLRP3 in ESCC, lead to MDSCs enrichment, weaken the body's antitumour immunity, and lead to CDDP treatment resistance. The effective elimination of Fn and the inhibition of MDSCs enrichment may provide new strategies and treatments for ESCC. HIGHLIGHTS: The survival of ESCC patients with Fn infection, high NLRP3 expression and MDSCs enrichment was significantly shortened. Fn infection could cause CDDP resistance in ESCC. Fn could induce the enrichment of MDSCs in the tumour microenvironment by activating NLRP3 in ESCC cells. Taylor & Francis 2022-04-18 /pmc/articles/PMC9891225/ /pubmed/35435776 http://dx.doi.org/10.1080/07853890.2022.2061045 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oncology
Liang, Mengxia
Liu, Yiwen
Zhang, Zheyuan
Yang, Haijun
Dai, Ningtao
Zhang, Ning
Sun, Wei
Guo, Yibo
Kong, Jinyu
Wang, Xiaopeng
Wang, Min
Zhou, Fuyou
Fusobacterium nucleatum induces MDSCs enrichment via activation the NLRP3 inflammosome in ESCC cells, leading to cisplatin resistance
title Fusobacterium nucleatum induces MDSCs enrichment via activation the NLRP3 inflammosome in ESCC cells, leading to cisplatin resistance
title_full Fusobacterium nucleatum induces MDSCs enrichment via activation the NLRP3 inflammosome in ESCC cells, leading to cisplatin resistance
title_fullStr Fusobacterium nucleatum induces MDSCs enrichment via activation the NLRP3 inflammosome in ESCC cells, leading to cisplatin resistance
title_full_unstemmed Fusobacterium nucleatum induces MDSCs enrichment via activation the NLRP3 inflammosome in ESCC cells, leading to cisplatin resistance
title_short Fusobacterium nucleatum induces MDSCs enrichment via activation the NLRP3 inflammosome in ESCC cells, leading to cisplatin resistance
title_sort fusobacterium nucleatum induces mdscs enrichment via activation the nlrp3 inflammosome in escc cells, leading to cisplatin resistance
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891225/
https://www.ncbi.nlm.nih.gov/pubmed/35435776
http://dx.doi.org/10.1080/07853890.2022.2061045
work_keys_str_mv AT liangmengxia fusobacteriumnucleatuminducesmdscsenrichmentviaactivationthenlrp3inflammosomeinescccellsleadingtocisplatinresistance
AT liuyiwen fusobacteriumnucleatuminducesmdscsenrichmentviaactivationthenlrp3inflammosomeinescccellsleadingtocisplatinresistance
AT zhangzheyuan fusobacteriumnucleatuminducesmdscsenrichmentviaactivationthenlrp3inflammosomeinescccellsleadingtocisplatinresistance
AT yanghaijun fusobacteriumnucleatuminducesmdscsenrichmentviaactivationthenlrp3inflammosomeinescccellsleadingtocisplatinresistance
AT dainingtao fusobacteriumnucleatuminducesmdscsenrichmentviaactivationthenlrp3inflammosomeinescccellsleadingtocisplatinresistance
AT zhangning fusobacteriumnucleatuminducesmdscsenrichmentviaactivationthenlrp3inflammosomeinescccellsleadingtocisplatinresistance
AT sunwei fusobacteriumnucleatuminducesmdscsenrichmentviaactivationthenlrp3inflammosomeinescccellsleadingtocisplatinresistance
AT guoyibo fusobacteriumnucleatuminducesmdscsenrichmentviaactivationthenlrp3inflammosomeinescccellsleadingtocisplatinresistance
AT kongjinyu fusobacteriumnucleatuminducesmdscsenrichmentviaactivationthenlrp3inflammosomeinescccellsleadingtocisplatinresistance
AT wangxiaopeng fusobacteriumnucleatuminducesmdscsenrichmentviaactivationthenlrp3inflammosomeinescccellsleadingtocisplatinresistance
AT wangmin fusobacteriumnucleatuminducesmdscsenrichmentviaactivationthenlrp3inflammosomeinescccellsleadingtocisplatinresistance
AT zhoufuyou fusobacteriumnucleatuminducesmdscsenrichmentviaactivationthenlrp3inflammosomeinescccellsleadingtocisplatinresistance